StockNews.AI
PFE
StockNews.AI
20 hrs

Pfizer Declares First-Quarter 2026 Dividend

1. Pfizer announces $0.43 quarterly dividend for Q1 2026. 2. The dividend will be paid on March 6, 2026. 3. This marks Pfizer's 349th consecutive quarterly dividend. 4. Pfizer emphasizes its commitment to healthcare innovation. 5. The company collaborates to improve access to healthcare globally.

7m saved
Insight

FAQ

Why Bullish?

The announcement of a consistent dividend demonstrates financial stability, attracting income-focused investors. Historical trends show share appreciation often follows consistent dividend announcements, as seen in previous quarters for Pfizer.

How important is it?

Given the significance of consistent dividends to investors, the announcement adds perceived value to PFE shares and may enhance market sentiment. As income stability is vital for investors, this announcement should be weighted heavily.

Why Short Term?

The dividend announcement is likely to influence stock performance until the payout date. Stock prices may see immediate fluctuations as investors respond to the assured income before the record date.

Related Companies

Board of Directors approves quarterly cash dividend of $0.43 per share

Pfizer Inc. (NYSE:PFE) today announced that its board of directors declared a $0.43 first-quarter 2026 dividend on the company's common stock, payable March 6, 2026, to holders of the Common Stock of record at the close of business on January 23, 2026. The first-quarter 2026 cash dividend will be the 349th consecutive quarterly dividend paid by Pfizer.

About Pfizer: Breakthroughs That Change Patients' Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Category: Financial

Media Contact: PfizerMediaRelations@Pfizer.com



Investor Contact: IR@Pfizer.com

Related News